Search

everythinglearnresearchcommunity

for

Search:↓

Drinking sweetened tea and late bedtimes increase the risk of hair loss in women.

Gender identity can be more diverse than just male or female.

Drinking sweetened tea and poor sleep increase the risk of hair loss in women.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

The document concludes that understanding hair follicles requires more research using computational methods and an integrative approach, considering the current limitations in hair treatment products.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Balding men have higher heart disease risk.

A systematic approach is crucial for managing hair loss in women.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Baldness might be caused by scalp weight pressing on hair follicles.

Testosterone increases hair testosterone levels, stress raises hair cortisol, and relationship status affects hormone levels.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Minoxidil effectively treats female pattern hair loss.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.